Canadian Pradaxa Acute Stroke Safety Study "CPASS"


Phase N/A Results N/A

Summary of Purpose

Study Design: This is a multicentre, prospective, open-label, single arm, phase IV registry study. No additional procedures are included in the study. Standard clinical data will be collected. This will include a physical examination and NIHSS score assessment at baseline. In addition, all neuro-imaging will be collected. Standard imaging includes a non-contrast CT brain at baseline and 7±2 days...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 24 October 2017.

1 Mar 2015 9 Apr 2015 1 Mar 2018 1 Jul 2018 1 Oct 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Probability Sample